Skip to content

YKL-40 and IL-6 Levels in Periodontal Disease

Effect of Non-Surgical Periodontal Therapy on Salivary and Gingival Crevicular Fluid YKL-40 and IL-6 Levels in Chronic Periodontitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03507868
Enrollment
52
Registered
2018-04-25
Start date
2016-09-30
Completion date
2018-01-31
Last updated
2018-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases

Brief summary

The primer aim of the study was to investigate saliva and gingival crevicular fluid (GCF) YKL-40 and also interleukin-6 (IL-6) levels in chronic periodontitis pathogenesis.

Detailed description

This study consisted of two groups: 26 periodontally healthy individuals and 26 generalized chronic periodontitis patients. Chronic periodontitis patients were received nonsurgical periodontal treatment. Clinical measurements were recorded, saliva and GCF samples were obtained before and at first and third months after periodontal therapy. Levels of YKL-40 and IL-6 in saliva and GCF were analyzed by enzyme-linked immunosorbent assay.

Interventions

Nonsurgical periodontal therapy includes oral hygiene education and scaling and root planning approaches to eliminate microbial dental plaque that is the primary etiology of periodontal diseases.

Sponsors

Zeynep Pinar KELES
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
26 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

Group 1 Inclusion Criteria: * No bone and attachment loss, * GI=0, PPD≤3mm, CAL≤3mm * Systematically healthy patients Group 2 Inclusion Criteria: * GI\>1, PPD≥5mm, CAL≥5mm with alveolar bone loss radiographically. * Systematically healthy patients

Exclusion criteria

* Aggressive Periodontitis, * Patients with any other systemic diseases, * Pregnant women and those in the lactation period, * Patients with smoking habit and taking medication * Patients received periodontal therapy in last 6 month

Design outcomes

Primary

MeasureTime frameDescription
YKL-40 levelsat first and third month after therapychanges in YKL-40 levels after periodontal therapy

Secondary

MeasureTime frameDescription
IL-6 levelsat first and third month after therapychanges in IL-6 levels after periodontal therapy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026